Efficacy and tolerability of 20% aluminum sesquichlorohydrate versus 20% aluminum chloride for the treatment of axillary hyperhidrosis: a randomized controlled trial

Phase 3

Completed

• Conditions: Primary axillary hyperhidrosis; Primary focal hyperhidrosis, Axillary hyperhidrosis, Aluminum chloride, Aluminum; sesquichlorohydrate, Aluminum salts, topical antiperspants

• Registration Number: TCTR20200814009
• Lead Sponsor: Faculty of Medicine, Srinakharinwirot University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2020-03-20
• Study Start: 2020-08-14
• Last Update Posted: 2024-08-19

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

The participants were 18 to 60 years of age with Sweating Intensity Visual Scale (SIVS)by
iodine-starch testof 2 or higher, and HDSS of grade 2 or higher for at least 6 months.

Exclusion Criteria

d history of allergy or sensitivity to aluminum salts, previous axillary treatments with
topical antiperspirant or anticholinergic medication within 2 weeks of the trial, treatment with
energy-based device in axillae within 6 months, treatment with botulinum toxin A or iontophoresis
within 12 months, and active skin diseases, for example, dermatological infections or eczema in
the treatment area. Use of OTC antiperspirant products were advised to be stopped 24 hours prior
to the day of screening, and during the study

Study & Design

• Study Type: Interventional
• Study Design: Not specified